Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The Lymphoma Study Association (LYSA) Registry Data

Blood (2019) 134 (Supplement_1): 4021.

https://doi.org/10.1182/blood-2019-129123

Published: 2019

Journal Articles

Follicular Lymphoma Response with CDK4/6 Inhibitor(Palbociclib) Utilized in the Setting of Metastatic Breast Cancer

Syed S Ali, Wilson Mertens

Blood (2017) 130 (Supplement 1): 5165.

https://doi.org/10.1182/blood.V130.Suppl_1.5165.5165

Published: 2017

Journal Articles

The Role of PLEKHA8 Gene in T Cell Lymphoblastic Leukemia

Tian Yuan, MD PhD, Yaling Yang, PhD, Wuping Li, MD PhD, Bing Xia, MD, Wen Xu, MD, Yizhuo Zhang, MD PhD, M. James You, MD PhD

Blood (2017) 130 (Supplement 1): 5122.

https://doi.org/10.1182/blood.V130.Suppl_1.5122.5122

Published: 2017

Journal Articles

Aspirin Inhibits Platelets from Reprogramming Breast Tumor Cells and Promoting Metastasis

Kellie Machlus, PhD, Kelly Johnson, PhD, Julia Ceglowski, Jodi Forward, Mason Tippy, Saleh El-Husayni, Rajesh Kulenthirarajan, Wendy Chen, MD, Joseph E. Italiano, Jr., PhD, Elisabeth Battinelli, MD PhD

Blood (2017) 130 (Supplement 1): 3629.

https://doi.org/10.1182/blood.V130.Suppl_1.3629.3629

Published: 2017

Journal Articles

Tamoxifen Directly Inhibits Platelet Activation, Angiogenic Potential and Platelet-Mediated Metastasis

Elisabeth M. Battinelli, MD PhD, Kelly Elizabeth Johnson, PhD, Jodi A Forward, Mason Tippy, BS, Rajesh Kulenthirarajan, Erica L. Mayer, MD, Joseph E Italiano, Jr., PhD

Blood (2016) 128 (22): 3723.

https://doi.org/10.1182/blood.V128.22.3723.3723

Published: 2016

Journal Articles

Anti-Tumor Responses By Ibrutinib and Anti-PD-1 Blockade Is Enhanced By Phosphatidylserine-Targeting Antibody Therapy

Jian Gong, MD/PhD, Michael Gray, PhD, Jeff Hutchins, PhD, Bruce Freimark, PhD

Blood (2016) 128 (22): 5379.

https://doi.org/10.1182/blood.V128.22.5379.5379

Published: 2016

Journal Articles

Enhance T Cell Immunotherapy By Targeting PIM-2 Kinase

Anusara Daenthanasanmak, PhD, Yongxia Wu, PhD, Supinya Iamsawat, MSc, Hung D Nguyen, PhD, Shikhar Mehrotra, PhD, Andrew Kraft, MD, Xue-Zhong Yu, PhD

Blood (2016) 128 (22): 815.

https://doi.org/10.1182/blood.V128.22.815.815

Published: 2016

Journal Articles

Diverse roles of cell-specific hypoxia-inducible factor 1 in cancer-associated hypercoagulation

Colin E. Evans, Pär-Ola Bendahl, Mattias Belting, Cristina Branco, Randall S. Johnson

Blood (2016) 127 (10): 1355–1360.

https://doi.org/10.1182/blood-2015-09-671982

Published: 2016

Journal Articles

Platelets Promote Breast Cancer Metastasis By Reprogramming Tumor Cells to Produce IL-8

Kelly Elizabeth Johnson, PhD, Kellie R Machlus, PhD, Saleh El-Husayni, Rajesh Kulenthirarajan, Jodi A Forward, Joseph E Italiano, Jr., PhD, Elisabeth M. Battinelli, MD PhD

Blood (2015) 126 (23): 2233.

https://doi.org/10.1182/blood.V126.23.2233.2233

Published: 2015

Journal Articles

Specifically Targeting the Interface Between HER1-HER3 Heterodimer on Breast Cancer to Limit Off-Target Effects Using Chimeric Antigen Receptor Designs with Improved T-Cell Energy Balance

Bipulendu Jena, PhD, Natalya Belousova, PhD, George T McNamara, PhD, David Rushworth, BS, Tiejuan Mi, MS, Helen Huls, BS, Richard E. Champlin, Laurence JN Cooper, MD PhD

Blood (2014) 124 (21): 2151.

https://doi.org/10.1182/blood.V124.21.2151.2151

Published: 2014

Journal Articles

Somatic Mutations of the Breast Cancer Amplified Sequence-1 (BCAS1 ), a Novel Leukemogenic Driver in Myelodysplastic Syndromes with Del(20q)

Valeria Visconte, PhD, Ali Tabarroki, MD, John Barnard, Li Zhang, Juraj Bodo, PhD, Reda Mahfouz, MD, Betty K. Hamilton, MD, Mikkael Sekeres, Anjali S. Advani, MD, Matt E. Kalaycio, MD, Yogen Saunthararajah, MD, Velizar Shivarov, MD, PhD, Shashirekha Shetty, PhD, Heesun J. Rogers, MD PhD, Ramon V. Tiu, MD

Blood (2014) 124 (21): 3250.

https://doi.org/10.1182/blood.V124.21.3250.3250

Published: 2014

Journal Articles

Anti-Myeloma Activity of a Novel Glutaminase Inhibitor CB-839

Deepika Sharma Das, PhD, Durgadevi Ravillah, PhD, Arghya Ray, PhD, Yan Song, PhD, Nikhil C. Munshi, MD, Paul G. Richardson, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD

Blood (2014) 124 (21): 3439.

https://doi.org/10.1182/blood.V124.21.3439.3439

Published: 2014

Journal Articles

Identification of a Novel and Efficacious Oral Proteasome Inhibitor As a Potential Clinical Development Candidate

Kwang-Ai Won, PhD, Byung Gyu Kim, Cheol-Kyu Jung, Eok Park, Eunbok Baek, Jonghoon Park, Seung-Wan Kang, Tae Hun Kim, Youngjoo Jung

Blood (2014) 124 (21): 4808.

https://doi.org/10.1182/blood.V124.21.4808.4808

Published: 2014

Journal Articles

Bone Marrow Mesenchymal Stem Cells: Pre-Metastatic Niche For Breast Cancer

Leonardo Julio Feldman, Sr., MD, Valeria B. Fernández Vallone, Hosoon Choi, Vivian Labovsky, Leandro M Martinez, raul H. Bordenave, Vera Milovic, Gregorio Jaimovich, Emilio Batagelj, Federico Dimase, Ana Rodriguez Villafañe, Norma A. Chasseing

Blood (2013) 122 (21): 4859.

https://doi.org/10.1182/blood.V122.21.4859.4859

Published: 2013

Journal Articles

Primary Breast Diffuse Large B Cell Lymphoma: A Distinct Clinical Entity

Matthew P Salzberg, Jocelyn C Maragulia, Oliver W. Press, MD, PhD, Thomas M Habermann, MD, Julie M Vose, MD, MBA, Martin Bast, BS, Ranjana H. Advani, MD, Andrew M. Evens, DO, MSc, Nahida Islam, MD, John P. Leonard, MD, Peter Martin, MD, Peter J Hosein, MD, Andrew D Zelenetz, MD, PhD, Izidore S Lossos, MD

Blood (2012) 120 (21): 1618.

https://doi.org/10.1182/blood.V120.21.1618.1618

Published: 2012

Journal Articles

Human Multiple Myeloma and Breast Cancer Cells Evade Immune Rejection Through Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6.

Mathias Witzens-Harig, MD, Dirk Hose, MD, PhD, Simone Jünger, Christina Pfirschke, Nisit Khandelwal, Anja Seckinger, MD, Heinke Conrad, Bettina Brackertz, Thierry Reme, Brigittte Gückel, Tobias Meissner, Michael Hundemer, Anthony D Ho, MD, Jean-Francois Rossi, MD, PhD, Kai Neben, MD, Helga Bernhard, MD, Hartmut Goldschmidt, MD, Bernard Klein, Philipp Beckhove

Blood (2012) 120 (21): 2942.

https://doi.org/10.1182/blood.V120.21.2942.2942

Published: 2012

Journal Articles

Investigation of KLF5 Function in Normal Hematopoiesis.

Nur Hezrin Shahrin, Anna L Brown, PhD, Sonya Diakiw, Richard J D'Andrea, PhD

Blood (2012) 120 (21): 2313.

https://doi.org/10.1182/blood.V120.21.2313.2313

Published: 2012

Journal Articles

Hsa-Mir-199b-5p Targets PODXL and DDR1: Decreased Levels of Mir-199b-5p Correlate with Elevated Expressions of PODXL and DDR1 in Acute Myeloid Leukemia

Amanda Favreau, Erin Cross, Pradeep Sathyanarayana

Blood (2011) 118 (21): 1463.

https://doi.org/10.1182/blood.V118.21.1463.1463

Published: 2011

Journal Articles

Is Multiple Sclerosis a Risk for Hypercoagulation States or Breast Cancer? A Case Report and a Literature Review to Assess Options

Lisa Thomas, MD, Qi Shi, MD, Sathyanarayanan Ramakrishnan, MD, Jihua Jia, MD, Linda Thomas-Hemak, MD

Blood (2011) 118 (21): 4665.

https://doi.org/10.1182/blood.V118.21.4665.4665

Published: 2011

Journal Articles

Eltrombopag Decreases Proliferation of Ovarian, Lung and Breast Tumor Cell Lines.

Connie L. Erickson-Miller, Jennifer Kirchner, Kodandaram Pillarisetti, Lone Ottesen, Yasser Mostafa Kamel, Yuan Liu, Anne-Marie Martin, Conrad Messam

Blood (2009) 114 (22): 2409.

https://doi.org/10.1182/blood.V114.22.2409.2409

Published: 2009

NARROW

Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The Lymphoma Study Association (LYSA) Registry Data

Follicular Lymphoma Response with CDK4/6 Inhibitor(Palbociclib) Utilized in the Setting of Metastatic Breast Cancer

The Role of PLEKHA8 Gene in T Cell Lymphoblastic Leukemia

Aspirin Inhibits Platelets from Reprogramming Breast Tumor Cells and Promoting Metastasis

Tamoxifen Directly Inhibits Platelet Activation, Angiogenic Potential and Platelet-Mediated Metastasis

Anti-Tumor Responses By Ibrutinib and Anti-PD-1 Blockade Is Enhanced By Phosphatidylserine-Targeting Antibody Therapy

Enhance T Cell Immunotherapy By Targeting PIM-2 Kinase

Diverse roles of cell-specific hypoxia-inducible factor 1 in cancer-associated hypercoagulation

Platelets Promote Breast Cancer Metastasis By Reprogramming Tumor Cells to Produce IL-8

Specifically Targeting the Interface Between HER1-HER3 Heterodimer on Breast Cancer to Limit Off-Target Effects Using Chimeric Antigen Receptor Designs with Improved T-Cell Energy Balance

Somatic Mutations of the Breast Cancer Amplified Sequence-1 (BCAS1 ), a Novel Leukemogenic Driver in Myelodysplastic Syndromes with Del(20q)

Anti-Myeloma Activity of a Novel Glutaminase Inhibitor CB-839

Identification of a Novel and Efficacious Oral Proteasome Inhibitor As a Potential Clinical Development Candidate

Bone Marrow Mesenchymal Stem Cells: Pre-Metastatic Niche For Breast Cancer

Primary Breast Diffuse Large B Cell Lymphoma: A Distinct Clinical Entity

Human Multiple Myeloma and Breast Cancer Cells Evade Immune Rejection Through Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6.

Investigation of KLF5 Function in Normal Hematopoiesis.

Hsa-Mir-199b-5p Targets PODXL and DDR1: Decreased Levels of Mir-199b-5p Correlate with Elevated Expressions of PODXL and DDR1 in Acute Myeloid Leukemia

Is Multiple Sclerosis a Risk for Hypercoagulation States or Breast Cancer? A Case Report and a Literature Review to Assess Options

Eltrombopag Decreases Proliferation of Ovarian, Lung and Breast Tumor Cell Lines.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only